Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PI3K‐α/mTOR/BRD4 inhibitor alone or in combination with other anti‐virals blocks replication of SARS‐CoV‐2 and its variants of concern including Delta and Omicron
Arpan Acharya, Anup S. Pathania, Kabita Pandey, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 4
Open Access | Times Cited: 18

Showing 18 citing articles:

COVID-19 drug discovery and treatment options
Jasper Fuk‐Woo Chan, Shuofeng Yuan, Hin Chu, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 7, pp. 391-407
Closed Access | Times Cited: 17
Binding of the SARS-CoV-2 envelope E protein to human BRD4 is essential for infection
Kendra R. Vann, Arpan Acharya, Suk Min Jang, et al.
Structure (2022) Vol. 30, Iss. 9, pp. 1224-1232.e5
Open Access | Times Cited: 29
9-aminominocycline potentiates the efficacy of EIDD-1931 and PF-332 by targeting the papain like protease enzyme of SARS-CoV-2
Kabita Pandey, Devin S. M. Lewis, Kyun Heo, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Investigation of the Host Kinome Response to Coronavirus Infection Reveals PI3K/mTOR Inhibitors as Betacoronavirus Antivirals
Ethan J. Fritch, Angie L. Mordant, Thomas S.K. Gilbert, et al.
Journal of Proteome Research (2023) Vol. 22, Iss. 10, pp. 3159-3177
Closed Access | Times Cited: 8
Natural hyperoside extracted from hawthorn exhibits antiviral activity against porcine epidemic diarrhea virus in vitro and in vivo
Jun Wang, Haibo Sun, Mingjun Su, et al.
Virology (2024) Vol. 594, pp. 110037-110037
Closed Access | Times Cited: 2
SRX3177, a CDK4/6-PI3K-BET inhibitor, in combination with an RdRp inhibitor, Molnupiravir, or an entry inhibitor MU-UNMC-2, has potent antiviral activity against the Omicron variant of SARS-CoV-2
Kabita Pandey, Arpan Acharya, Dhananjaya Pal, et al.
Antiviral Research (2024) Vol. 227, pp. 105904-105904
Closed Access | Times Cited: 2
Viral Hijacking of BET Proteins
Irene P. Chen, Mélanie Ott
Viruses (2022) Vol. 14, Iss. 10, pp. 2274-2274
Open Access | Times Cited: 9
mTOR signaling regulates Zika virus replication bidirectionally through autophagy and protein translation
Bin Liu, Yahui Zhang, Hao Ren, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Closed Access | Times Cited: 9
Design of novel and highly selective SARS-CoV-2 main protease inhibitors
Adi Narayana Reddy Poli, Ian Tietjen, Nitesh Kumar Nandwana, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 10
Open Access | Times Cited: 1
Efficient trapping and destruction of SARS-CoV-2 using PECO-assisted Molekule air purifiers in the laboratory and real-world settings
Arpan Acharya, Kerri Surbaugh, Michellie Thurman, et al.
Ecotoxicology and Environmental Safety (2023) Vol. 264, pp. 115487-115487
Open Access | Times Cited: 3
Combining antiviral drugs with BET inhibitors is beneficial in combatting SARS‐CoV‐2 infection
Arpan Acharya, Tatiana G. Kutateladze, Siddappa N. Byrareddy
Clinical and Translational Discovery (2022) Vol. 2, Iss. 2
Open Access | Times Cited: 5
Discovery of novel bromodomain-containing protein 4 (BRD4-BD1) inhibitors combined with 3d-QSAR, molecular docking and molecular dynamics in silico
Rong Liu, XiaoDie Chen, Jiali Li, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-18
Closed Access
FRET-based in vitro assay for rapid detecting of SARS-CoV-2 entry inhibitors
Chunyu Yan, Qinglong Qiao, Wei Zhou, et al.
Chinese Chemical Letters (2024), pp. 110258-110258
Closed Access
Proteomic landscape of astrocytes and pericytes infected with HIV/SARS-CoV-2 mono/co-infection, impacting on neurological complications
Arpan Acharya, Anoop T. Ambikan, Michellie Thurman, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Promoting autophagy to mitigate coronavirus disease pathology in the elderly
Abby Lund Da Costa, Het Mehta, Ramkumar Mathur
Clinical and Translational Discovery (2022) Vol. 2, Iss. 2
Open Access | Times Cited: 2
Catching BETs by viruses
Mohamad Zandian, Irene P. Chen, Siddappa N. Byrareddy, et al.
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2022) Vol. 1865, Iss. 7, pp. 194859-194859
Open Access | Times Cited: 2
A commentary on “PI3K‐α/mTOR/BRD4 inhibitor alone or in combination with other anti‐virals blocks replication of SARS‐CoV‐2 and its variants of concern including Delta and Omicron”
Sakthijothi Muthu, Sundararajan Venkatesh
Clinical and Translational Discovery (2022) Vol. 2, Iss. 2
Open Access | Times Cited: 1
Characterization of multiple interactions between the envelope E protein of SARS-CoV-2 and human BRD4
Mohamad Zandian, Suk Min Jang, Catherine Lachance, et al.
STAR Protocols (2022) Vol. 3, Iss. 4, pp. 101853-101853
Open Access
Page 1

Scroll to top